Inhibikase Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
0.00 |
8.64 |
20.36 |
108.21 |
327.88 |
| Przychód Δ r/r |
0.00% |
-100.00% |
inf% |
135.67% |
431.44% |
203.00% |
| Przychód (min) |
0.00 |
0.00 |
8.64 |
20.36 |
108.21 |
327.88 |
| Przychód (max) |
0.00 |
0.00 |
8.64 |
20.36 |
108.21 |
327.88 |
| EBITDA (średnia) |
0.00 |
0.00 |
-5.18 |
-12.22 |
-64.93 |
-196.73 |
| EBIT (średnia) |
0.00 |
0.00 |
-5.18 |
-12.22 |
-64.93 |
-196.73 |
| EBIT % |
0.00% |
0.00% |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
| Zysk netto (średni) |
-21.31 |
-9.48 |
-10.31 |
-9.37 |
0.24 |
23.71 |
| Zysk netto % |
-2130958000.00% |
-inf% |
-119.38% |
-46.00% |
0.22% |
7.23% |
| EPS (średnia) |
-0.90 |
-0.40 |
-0.43 |
-0.40 |
0.01 |
1.00 |
| Liczba analityków (Przychody) |
1 |
0 |
2 |
2 |
1 |
1 |
| Liczba analityków (EPS) |
2 |
2 |
2 |
2 |
1 |
1 |
| symbol |
IKT |
IKT |
IKT |
IKT |
IKT |
IKT |